{
  "id": "ff6920eb84f11fc0",
  "title": "How A Wall Street Analyst Started A $4 Billion Obesity Drug Company",
  "description": "20260104T140000Z",
  "content": "",
  "source": "forbes.com",
  "source_url": "https://www.forbes.com/sites/amyfeldman/2026/01/04/how-a-wall-street-analyst-started-a-4-billion-obesity-drug-company/",
  "published_at": "20260104T140000Z",
  "fetched_at": "2026-01-05T00:25:31.293310+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.forbes.com/sites/amyfeldman/2026/01/04/how-a-wall-street-analyst-started-a-4-billion-obesity-drug-company/",
    "url_mobile": "",
    "title": "How A Wall Street Analyst Started A $4 Billion Obesity Drug Company",
    "seendate": "20260104T140000Z",
    "socialimage": "https://imageio.forbes.com/specials-images/imageserve/694076022f2d1160a20b6989/0x0.jpg?format=jpg&crop=2250,1266,x0,y727,safe&fit=bounds",
    "domain": "forbes.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}